skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Kyriakopoulos, Christos E ; Chen, Yu-Hui ; Carducci, Michael A ; Liu, Glenn ; Jarrard, David F ; Hahn, Noah M ; Shevrin, Daniel H ; Dreicer, Robert ; Hussain, Maha ; Eisenberger, Mario ; Kohli, Manish ; Plimack, Elizabeth R ; Vogelzang, Nicholas J ; Picus, Joel ; Cooney, Matthew M ; Garcia, Jorge A ; DiPaola, Robert S ; Sweeney, Christopher J

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Sikov, William M ; Berry, Donald A ; Perou, Charles M ; Singh, Baljit ; Cirrincione, Constance T ; Tolaney, Sara M ; Kuzma, Charles S ; Pluard, Timothy J ; Somlo, George ; Port, Elisa R ; Golshan, Mehra ; Bellon, Jennifer R ; Collyar, Deborah ; Hahn, Olwen M ; Carey, Lisa A ; Hudis, Clifford A ; Winer, Eric P

Journal of clinical oncology, 2015-01, Vol.33 (1), p.13-21 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer

Liao, Zhongxing ; Lee, J Jack ; Komaki, Ritsuko ; Gomez, Daniel R ; O'Reilly, Michael S ; Fossella, Frank V ; Blumenschein, Jr, George R ; Heymach, John V ; Vaporciyan, Ara A ; Swisher, Stephen G ; Allen, Pamela K ; Choi, Noah Chan ; DeLaney, Thomas F ; Hahn, Stephen M ; Cox, James D ; Lu, Charles S ; Mohan, Radhe

Journal of clinical oncology, 2018-06, Vol.36 (18), p.1813-1822 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

WAGLE, Nikhil ; EMERY, Caroline ; MEYERSON, Matthew ; GARRAWAY, Levi A ; BERGER, Michael F ; DAVIS, Matthew J ; SAWYER, Allison ; POCHANARD, Panisa ; KEHOE, Sarah M ; JOHANNESSEN, Cory M ; MACCONAILL, Laura E ; HAHN, William C

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3085-3096 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial

Hummel, Susanna B ; van Lankveld, Jacques J D M ; Oldenburg, Hester S A ; Hahn, Daniela E E ; Kieffer, Jacobien M ; Gerritsma, Miranda A ; Kuenen, Marianne A ; Bijker, Nina ; Borgstein, Paul J ; Heuff, Gijsbert ; Lopes Cardozo, Alexander M F ; Plaisier, Peter W ; Rijna, Herman ; van der Meij, Suzan ; van Dulken, Eric J ; Vrouenraets, Bart C ; Broomans, Eva ; Aaronson, Neil K

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1328-1340 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer

Vuky, Jacqueline ; Balar, Arjun V ; Castellano, Daniel ; O'Donnell, Peter H ; Grivas, Petros ; Bellmunt, Joaquim ; Powles, Thomas ; Bajorin, Dean ; Hahn, Noah M ; Savage, Mary J ; Fang, Xiao ; Godwin, James Luke ; Frenkl, Tara L ; Homet Moreno, Blanca ; de Wit, Ronald ; Plimack, Elizabeth R

Journal of clinical oncology, 2020-08, Vol.38 (23), p.2658-2666 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

Eastham, James A ; Heller, Glenn ; Halabi, Susan ; Monk, 3rd, J Paul ; Beltran, Himisha ; Gleave, Martin ; Evans, Christopher P ; Clinton, Steven K ; Szmulewitz, Russell Z ; Coleman, Jonathan ; Hillman, David W ; Watt, Colleen R ; George, Saby ; Sanda, Martin G ; Hahn, Olwen M ; Taplin, Mary-Ellen ; Parsons, J Kellogg ; Mohler, James L ; Small, Eric J ; Morris, Michael J

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3042-3050 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)

Boughey, Judy C ; Rosenkranz, Kari M ; Ballman, Karla V ; McCall, Linda ; Haffty, Bruce G ; Cuttino, Laurie W ; Kubicky, Charlotte D ; Le-Petross, Huong T ; Giuliano, Armando E ; Van Zee, Kimberly J ; Hunt, Kelly K ; Hahn, Olwen M ; Carey, Lisa A ; Partridge, Ann H

Journal of clinical oncology, 2023-06, Vol.41 (17), p.3184-3193 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
9
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

Choueiri, Toni K ; Halabi, Susan ; Sanford, Ben L ; Hahn, Olwen ; Michaelson, M Dror ; Walsh, Meghara K ; Feldman, Darren R ; Olencki, Thomas ; Picus, Joel ; Small, Eric J ; Dakhil, Shaker ; George, Daniel J ; Morris, Michael J

Journal of clinical oncology, 2017-02, Vol.35 (6), p.591-597 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75
Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

HAHN, Noah M ; STADLER, Walter M ; ZON, Robin T ; WATERHOUSE, David ; PICUS, Joel ; NATTAM, Sreenivasa ; JOHNSON, Cynthia S ; PERKINS, Susan M ; WADDELL, Mary Jane ; SWEENEY, Christopher J

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1525-1530 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.